Lipid abnormalities in chronic renal failure patients undergoing hemodialysis;Trastornos lipídicos en pacientes con insuficiencia renal crónica en hemodiálisis

Medicina

Volumn 61, Issue 2, 2001, Pages 142-146

  De Gomez Dumm, Nelva T ^a   Giammona, Ana M ^b   Touceda, Luis A ^b   Raimondi, Clemente ^b  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b NONE

Author keywords

Chronic renal failure; Dialysis membranes; Erythrocytes; Hemodialysis; Polyunsaturated fatty acids; Triglycerides

Indexed keywords

BIOMATERIAL; CELLULOSE; CUPROPHANE; DRUG DERIVATIVE; LIPID; POLYMER; POLYSULFONE P 1700; SULFONE; TRIACYLGLYCEROL; UNSATURATED FATTY ACID;

ADULT; ARTICLE; ARTIFICIAL MEMBRANE; BLOOD; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; FEMALE; HUMAN; MALE; METABOLISM; RENAL REPLACEMENT THERAPY; TIME;

ADULT; BIOCOMPATIBLE MATERIALS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CELLULOSE; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LIPIDS; MALE; MEMBRANES, ARTIFICIAL; POLYMERS; RENAL DIALYSIS; SULFONES; TIME FACTORS; TRIGLYCERIDES;

EID: 0035221712     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Green D, Stone NJ, Krumlowsky A. Putative atherogenic factors in patients with chronic renal failure. Prog Cardiovasc Dis 1983; 26: 133-44.
2. Castelli, WP. The triglyceride issue: a view from Framingham. Am Heart J 1986; 112: 432-7.
3. Hahn R, Oette K, Mondorf H, Finke K, Sieberth HG. Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias. Atherosclerosis 1983; 48: 279-88.
4. Sinclair HM. Essential fatty acids - an historical perspective. Biochem Soc Trans 1990; 18: 756-61.
5. Stubbs CD, Smith AD. Essential fatty acids in membrane: physical properties and function. Biochem Soc Trans 1990; 18: 779-81.
6. Wood JN. Essential fatty acids and their metabolites in signal transduction. Biochem Soc Trans 1990; 18: 785-6
7. Wood DA, Riemersma RA, Butler S, et al. Linoleic and eicosapentaenoic acids in adipose tissue and platelets and risk of coronary heart disease. Lancet 1987; 177-83.
8. Kaysen GA. Hyperlipidemia of chronic renal failure. Blood Purif 1994; 12: 60-7.
9. Peck LW, Monsen ER, Ahmad S. Effect of three sources of long-chain fatty acids on the plasma fatty acid profile, plasma prostaglandin E2 concentrations, and pruritus symptoms in hemodialysis patients. Am J Clin Nut. 1996; 64: 210-4.
10. Garda HA, Brenner RR. Short-chain aliphatic alcohols increase rat liver microsomal membrane fluidity and affect the activities of some microsomal membrane-bound enzymes. Biochim Biophys Acta 1984; 769: 160-70 .
11. Brown AJ, Pang E, Roberts DCK. Erythrocyte eicosapentaenoic acid versus docosahexaenoic acid as a marker for fish and fish oil consumption. Prostaglandins Leukot Essent Fatty Acids 1991; 44: 103-6.
12. Attman PO, Alaupovic P. Lipid abnormalities in chronic renal insufficiency. Kidney Int 1991; 39: S16-S23.
13. House AA, Wells GA, Donnelly JG, Nadler SP, Hebert PC. Randomized trial of high-flux vs. low-flux haemodialysis: effects on homocysteine and lipids. Nephrol Dial Transplant 2000; 15: 1029-34.
14. Tanaka H, Nishikawa O, Yukawa S, Yoshimoto M, Nishide I. Effects of hemodialysis membrane on serum lipid profile of maintenance hemodialysis patients. Nippon Jinzo Gakkai Shi 1999; 41: 1-7.
15. Peuchant E, Salles C, Vallot C, Wone C, Jensen R. Increase of erythrocyte resistance to hemolysis and modification of membrane lipids induced by hemodialysis. Clin Chim Acta 1998; 178: 271-82.